España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Rain Enhancement
RAIN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.20
0.08
1.89%
At close: -
$4.01
-0.19
-4.52%
After Hours: 5:03 PM EDT
Get Report
Comment
Rain Enhancement (RAIN) Forecast
News
Earnings
Rain Enhancement (RAIN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Rain Enhancement (NASDAQ:RAIN) Stock
Rain Enhancement Stock (NASDAQ: RAIN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 06, 2025
Rain Enhancement Technologies Shares Resume T...
Benzinga Newsdesk
CORRECTION: Rain Enhancement Technologies Hal...
Benzinga Newsdesk
Friday, January 19, 2024
Rain Oncology Says Pursuant To Proposed Deal ...
Benzinga Newsdesk
Thursday, December 14, 2023
Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
Vandana Singh
Reported Earlier, Rain Oncology To Be Acquire...
Benzinga Newsdesk
Thursday, November 09, 2023
Rain Oncology Q3 EPS $(0.19) Beats $(0.27) Es...
Benzinga Newsdesk
Monday, October 16, 2023
Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying
Lisa Levin
Rain Oncology Confirms Receipt Of Unsolicited...
Benzinga Newsdesk
Friday, October 13, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 18, 2023
Citigroup Maintains Neutral on Rain Oncology,...
Benzinga Newsdesk
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, September 07, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, August 28, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, August 10, 2023
Rain Oncology Q2 EPS $(0.61) Misses $(0.51) E...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Monday, July 24, 2023
10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More
Chris Katje
Friday, June 16, 2023
Rain Oncology Option Alert: Sep 15 $5 Puts Sw...
Charles Gross
Monday, June 05, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 5, 2023
Benzinga Insights
Mizuho Downgrades Rain Oncology to Neutral, L...
Benzinga Newsdesk
Friday, June 02, 2023
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Rain Oncology 10% Owner Makes $1.16M Stock Purchase
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
Lisa Levin
HC Wainwright & Co. Reiterates Neutral on Rai...
Benzinga Newsdesk
Thursday, June 01, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, May 30, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Roth MKM Downgrades Rain Oncology to Neutral,...
Benzinga Newsdesk
EF Hutton Maintains Hold on Rain Oncology, Lo...
Benzinga Newsdesk
Rain Oncology Provides Company Update And Outlines Strategic Priorities Of Milademetan Clinical Programs; Workforce Reduction Of ~65% Of The Company's Employees; With A Transition Of Chief Medical Officer Responsibilities
Happy Mohamed
Thursday, May 25, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, May 23, 2023
Analyst Expectations for Rain Oncology's Future
Benzinga Insights
Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
Priya Nigam
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Benzinga Insights
Citigroup Downgrades Rain Oncology to Neutral...
Benzinga Newsdesk
JonesTrading Downgrades Rain Oncology to Hold
Benzinga Newsdesk
HC Wainwright & Co. Downgrades Rain Oncology ...
Benzinga Newsdesk
Piper Sandler Downgrades Rain Oncology to Neu...
Benzinga Newsdesk
Oppenheimer Downgrades Rain Oncology to Perfo...
Benzinga Newsdesk
EF Hutton Downgrades Rain Oncology to Hold, L...
Benzinga Newsdesk
Monday, May 22, 2023
Rain Oncology Shares Plummet: Company Discloses Disappointing Cancer Study Data After Delaying Readout
Vandana Singh
Dow Tumbles 100 Points; Micron Technology Shares Plunge
Lisa Levin
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher
Lisa Levin
Rain Oncology shares are trading lower after ...
Benzinga Newsdesk
US Stocks Mixed; Nordic American Tankers Posts Upbeat Results
Lisa Levin
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch